Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sanford

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Drugs|July 3, 2013
Mirabegron: a review of its use in patients with overactive bladder syndromeMark Sanford
Drugs|February 24, 2012
RilpivirineMark Sanford
Drugs|July 26, 2014
OnabotulinumtoxinA (Botox(®)): a review of its use in the treatment of urinary incontinence in patients with multiple sclerosis or subcervical spinal cord injuryMark Sanford
Drugs & Aging|August 20, 2013
Avanafil: a review of its use in patients with erectile dysfunctionMark Sanford
Drugs|November 5, 2014
Dulaglutide: first global approvalMark Sanford
Clinical Drug Investigation|June 5, 2014
Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertensionMark Sanford
Drugs|June 13, 2012
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): in older adultsMark Sanford
CNS Drugs|December 25, 2012
Lurasidone : in the treatment of schizophreniaMark Sanford
Evidence-Based Mental Health|August 16, 2002
A group of cognitive therapy programme reduced depressive episodes in at risk adolescents at 12 months of follow upMark Sanford
Drugs|August 7, 2010
Roflumilast: in chronic obstructive pulmonary diseaseMark Sanford
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Drugs|July 3, 2013
Mirabegron: a review of its use in patients with overactive bladder syndromeMark Sanford
Drugs|February 24, 2012
RilpivirineMark Sanford
Drugs|July 26, 2014
OnabotulinumtoxinA (Botox(®)): a review of its use in the treatment of urinary incontinence in patients with multiple sclerosis or subcervical spinal cord injuryMark Sanford
Drugs & Aging|August 20, 2013
Avanafil: a review of its use in patients with erectile dysfunctionMark Sanford
Drugs|November 5, 2014
Dulaglutide: first global approvalMark Sanford
Clinical Drug Investigation|June 5, 2014
Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertensionMark Sanford
Drugs|June 13, 2012
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): in older adultsMark Sanford
CNS Drugs|December 25, 2012
Lurasidone : in the treatment of schizophreniaMark Sanford
Evidence-Based Mental Health|August 16, 2002
A group of cognitive therapy programme reduced depressive episodes in at risk adolescents at 12 months of follow upMark Sanford
Drugs|August 7, 2010
Roflumilast: in chronic obstructive pulmonary diseaseMark Sanford
Pageof 7